GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Regulators of Cancer Immunotherapy Response

$497,881
Xiaole Shirley Liu · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Role of the stromal microenvironment in B-cell lymphoma progression and immune escape

$497,796
Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Synthetic lethality by targeting the core senescent mechanism in lung cancer.

$497,781
Xiao-Fan Wang · Duke University · R01 · FY2020 · CA

Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer

$497,668
Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2020 · CA

Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma

$497,607
Darell D Bigner · Duke University · P01 · FY2021 · CA

Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer

$497,575
Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2025 · CA

Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer

$497,573
Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2023 · CA

Dissecting and Targeting MAPK - PPARG Crosstalk in Bladder Cancer

$497,544
Kent W Mouw · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Disease Progression Modeling of Bladder Cancer

$497,514
Steve Goodison · Mayo Clinic Jacksonville · R01 · FY2025 · CA

Developing novel bispecific antibodies for cancer treatment

$497,359
Zhen Fan · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation

$497,352
Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2023 · CA

Leader cell development and function in Breast Tumor Collective Migration

$497,352
Gregory Longmore · Washington University · R01 · FY2023 · CA

Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression

$497,318
Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA

A Critical Role for Leukotriene B4 in Lymphedema

$497,241
Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2022 · HL

Pancreatic cancer-associated fibroblasts: function, detection, and regulation

$497,182
Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA

Quantification of gene expression in targeted rare cells in vivo

$497,163
Timothy R Brazelton · Children'S Hosp Of Philadelphia · RC1 · FY2009 · HG

Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody

$497,137
Paul Mathew · Tufts Medical Center · R01 · FY2024 · CA

Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence

$497,046
Veronika Fedirko · Emory University · R01 · FY2019 · CA

Cholesterol metabolism in mesenchymal colorectal cancer

$496,987
Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues

$496,959
Gabriel Popescu · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA

The Tumor Microenvironment and Lymphatic Remodeling in Postpartum Breast Cancer

$496,877
Jasmine Alise McDonald · Columbia University Health Sciences · R01 · FY2025 · CA

Dissecting the NRG4 hormonal checkpoint in metabolic liver disease

$496,844
Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2021 · DK

Environmental Effect on the Mammary Gland across the Lifespan

$496,746
Zena Werb · University Of California, San Francisco · U01 · FY2010 · ES

Dual targeting of XPO1 and BTK in B cell malignancies

$496,655
Rosa Lapalombella · Ohio State University · R01 · FY2019 · CA

Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis

$496,626
Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2019 · CA